Current Edition


Former Editas CEO Bosley joins UK venture capital firm

Dive Brief: Katrine Bosley, the former CEO of gene editing biotech company Editas Medicine, has joined U.K.-based Advent Life Sciences as a venture partner, the …

Continue Reading →

Editas’ executive shake up continues

Dive Brief: Editas Medicine, a biotechnology company focused on CRISPR gene editing, has fired its chief medical officer, adding to a series of executive-level change-ups …

Continue Reading →